Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma

অনুরূপ উপাদানগুলি

• Characterization of CD8(+) T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL)
  অনুযায়ী: Benteyn, Daphné, অন্যান্য
  প্রকাশিত: (2013)
• Clinical trials with MRNA electroporated dendritic cells for stage III/IV melanoma patients
  অনুযায়ী: Wilgenhof, Sofie, অন্যান্য
  প্রকাশিত: (2015)
• TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
  অনুযায়ী: De Keersmaecker, Brenda, অন্যান্য
  প্রকাশিত: (2020)
• TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
  অনুযায়ী: Bart Neyns, অন্যান্য
  প্রকাশিত: (2020-05-01)
• Patterns of Response in Patients with Pretreated Metastatic Melanoma who Received Ipilimumab 3 mg/kg in a European Expanded Access Program: Five Illustrative Case Reports
  অনুযায়ী: Wilgenhof, Sofie, অন্যান্য
  প্রকাশিত: (2012)